Stromal cell CD9 regulates differentiation of hematopoietic stem/progenitor cells

被引:47
作者
Aoyama, K
Oritani, K
Yokota, T
Ishikawa, J
Nishiura, T
Miyake, K
Kanakura, Y
Tomiyama, Y
Kincade, PW
Matsuzawa, Y
机构
[1] Osaka Univ, Sch Med, Dept Internal Med 2, Suita, Osaka 5650871, Japan
[2] Saga Med Sch, Dept Immunol, Saga, Japan
[3] Osaka Univ, Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan
[4] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
关键词
D O I
10.1182/blood.V93.8.2586.408k23_2586_2594
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD9 belongs to the transmembrane 4 superfamily, and has been shown to influence cell proliferation, motility, and adhesion. We show here that ligation of CD9 modifies proliferation and/or differentiation of hematopoietic stem/progenitors. Pluripotent EML-C1 hematopoietic cells were cocultured with MS-5 stromal cells in the presence of KMC8.8, an anti-CDS antibody. Numbers of recovered EML-C1 cells were slightly reduced and the antibody caused the hematopoietic cells to migrate beneath the adherent stromal cell layer. Of particular interest, EML-C1 cells recovered from CD9-ligated cultures had undifferentiated properties. Separate pretreatment of the two cell types with antibody showed that stromal-cell CD9 mediated these responses. Spontaneous expression of erythroid marker was completely blocked and there was a shift towards undifferentiated clonogenic progenitors. Immunoprecipitation studies showed that stromal-cell CD9 associates with the beta 1 subunit of integrin, as well as a novel 100 kD protein. Antibody cross-linking of cell surface CD9 increased the amount of 100 kD protein that was subsequently coprecipitated with CD9. These observations show that stromal-cell CD9 influences physical interactions with hematopoietic cells and may be one factor that determines the degree of stem cell differentiation. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:2586 / 2594
页数:9
相关论文
共 46 条
[1]   Ex vivo expansion of haemopoietic progenitor cells [J].
Alcorn, MJ ;
Holyoake, TL .
BLOOD REVIEWS, 1996, 10 (03) :167-176
[2]  
ANTON ES, 1995, J NEUROSCI, V15, P584
[3]  
BREEMS DA, 1994, LEUKEMIA, V8, P1095
[4]  
BRUNNER G, 1994, BLOOD, V83, P2115
[5]   REGULATION OF HEMATOPOIESIS BY BONE-MARROW STROMAL CELLS AND THEIR PRODUCTS [J].
DORSHKIND, K .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :111-137
[6]  
HADJIARGYROU M, 1995, J NEUROSCI, V15, P574
[7]   ENKEPHALINS STIMULATE LEUKEMIA-CELL MIGRATION AND SURFACE EXPRESSION OF CD9 [J].
HEAGY, W ;
DUCA, K ;
FINBERG, RW .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1366-1374
[8]   THE MEMBRANE-PROTEIN CDB/DRAP-27 POTENTIATES THE JUXTACRINE GROWTH-FACTOR ACTIVITY OF THE MEMBRANE-ANCHORED HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR [J].
HIGASHIYAMA, S ;
IWAMOTO, R ;
GOISHI, K ;
RAAB, G ;
TANIGUCHI, N ;
KLAGSBRUN, M ;
MEKADA, E .
JOURNAL OF CELL BIOLOGY, 1995, 128 (05) :929-938
[9]   Analysis of the tetraspanin CD9-integrin alpha(IIb)beta(3) (GPIIb-IIIa) complex in platelet membranes and transfected cells [J].
Indig, FE ;
DiazGonzalez, F ;
Ginsberg, MH .
BIOCHEMICAL JOURNAL, 1997, 327 :291-298
[10]  
ISSAAD C, 1993, BLOOD, V81, P2916